MORELLO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 4.042
AS - Asia 2.719
EU - Europa 2.561
SA - Sud America 491
AF - Africa 86
OC - Oceania 12
Totale 9.911
Nazione #
US - Stati Uniti d'America 3.907
SG - Singapore 1.130
IT - Italia 932
CN - Cina 644
BR - Brasile 396
PL - Polonia 314
DE - Germania 271
HK - Hong Kong 250
FI - Finlandia 218
VN - Vietnam 208
UA - Ucraina 165
FR - Francia 151
BD - Bangladesh 136
GB - Regno Unito 123
RU - Federazione Russa 99
IN - India 83
TR - Turchia 80
CA - Canada 74
IE - Irlanda 50
NL - Olanda 45
SE - Svezia 45
MX - Messico 39
CZ - Repubblica Ceca 31
JP - Giappone 29
IQ - Iraq 28
ES - Italia 27
AR - Argentina 24
ZA - Sudafrica 23
BE - Belgio 21
ID - Indonesia 20
EC - Ecuador 18
CO - Colombia 15
TH - Thailandia 14
AT - Austria 13
PK - Pakistan 13
VE - Venezuela 13
MA - Marocco 12
AU - Australia 11
EG - Egitto 11
MY - Malesia 11
ET - Etiopia 10
PT - Portogallo 10
GR - Grecia 9
PY - Paraguay 8
PH - Filippine 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
UY - Uruguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DK - Danimarca 5
GH - Ghana 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 5
KE - Kenya 5
PE - Perù 5
CL - Cile 4
LK - Sri Lanka 4
LT - Lituania 4
NO - Norvegia 4
NP - Nepal 4
TW - Taiwan 4
CR - Costa Rica 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TN - Tunisia 3
UG - Uganda 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
EE - Estonia 1
HN - Honduras 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.909
Città #
Singapore 661
Ashburn 450
San Jose 365
Warsaw 303
Hong Kong 246
Fairfield 238
New York 202
The Dalles 163
Beijing 155
Helsinki 154
Brescia 149
Woodbridge 149
Chandler 139
Los Angeles 127
Jacksonville 125
Seattle 119
Munich 115
Houston 111
Ann Arbor 109
Dallas 104
Milan 98
Wilmington 93
Lauterbourg 81
Princeton 77
Des Moines 67
Cambridge 66
Rome 62
Ho Chi Minh City 60
Council Bluffs 59
Istanbul 54
Dublin 49
Boardman 47
Hanoi 46
São Paulo 44
Shanghai 43
Turku 43
Santa Clara 41
San Francisco 38
Chicago 36
Buffalo 34
Moscow 33
Redondo Beach 29
Orem 27
Nanjing 25
Toronto 25
Frankfurt am Main 24
Tokyo 24
London 23
Naples 23
Brno 22
Nuremberg 22
Brooklyn 20
Chennai 20
Montreal 20
Turin 20
Brussels 19
Phoenix 19
Charlotte 18
Denver 18
Mexico City 18
Stockholm 18
Florence 16
Tianjin 16
Boston 15
Johannesburg 15
Poplar 15
Changsha 14
Pune 14
Verona 13
Amsterdam 12
Atlanta 12
Baghdad 12
Mumbai 12
Paris 12
Jinan 11
Lappeenranta 11
Manchester 11
San Diego 11
Barlassina 10
Wroclaw 10
Addis Ababa 9
Guayaquil 9
Haiphong 9
Pavia 9
Shenyang 9
Bari 8
Belo Horizonte 8
Bergamo 8
Da Nang 8
Romola 8
Bangkok 7
Bologna 7
Bosio 7
Brasília 7
Cagliari 7
Gorlago 7
Guangzhou 7
Olomouc 7
Pescara 7
Rio de Janeiro 7
Totale 6.186
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 295
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 293
Malnutrizione, valutazione nutrizionale e aspetti dietetici 222
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
OUR FOOD, OUR HEALTH: NOURISHING BIODIVERSITY TO HEAL OURSELVES AND THE PLANET Slow Food’s Position Paper on Food and Health 199
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 198
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults 178
Advances in CMV Management: A Single Center Real-Life Experience 177
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 172
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 170
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 167
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 164
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 162
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 158
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 157
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 154
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 149
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 146
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 145
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 144
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 140
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 135
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 135
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 131
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 131
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study 130
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 130
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 130
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 129
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 128
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 128
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 127
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 126
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 126
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 124
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. 123
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 121
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 121
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 120
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 120
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. 118
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 117
P. aeruginosa bloodstream infections among hematological patients: an old or new question? 115
Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS) 114
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 113
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 111
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 109
Nutritional strategies to improve VRE control 109
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 107
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 106
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 105
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 104
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 102
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 101
RIC Allogeneic Transplantation Improves the Overall and Progression-Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLA-Typing and Donor Availability. 101
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability 101
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 100
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 97
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 97
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 97
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 96
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 95
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 93
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 90
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 87
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 78
I diritti del malato 75
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 74
Aspetti Clinici della cGVHD polmonare 74
Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability. 74
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 73
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 72
Moving the Care Process in the in-Home Context: The Therapeutic Prescription 69
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 64
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 59
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 56
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 48
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 34
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 33
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 30
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 23
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 21
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 4
Totale 10.040
Categoria #
all - tutte 44.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022378 28 31 7 29 11 33 16 32 18 64 28 81
2022/2023451 54 12 18 40 44 99 3 54 53 13 30 31
2023/2024675 40 16 55 38 34 156 28 26 118 9 17 138
2024/20252.054 41 54 24 188 178 165 135 132 323 181 350 283
2025/20264.746 357 419 289 577 483 404 803 245 322 446 233 168
Totale 10.040